HOME >> MEDICINE >> NEWS
New clinical research study evaluates novel cell therapy

CHICAGO- Physicians at Rush University Medical Center are testing whether a novel cell therapy using retinal pigment epithelial (RPE) cells attached to tiny gelatin bead microcarriers implanted in the brain can improve the symptoms of Parkinson's disease.

The investigational cellular product (Spheramine), which is being evaluated in a new clinical study called STEPS1, consists of RPE cells attached to microcarriers. RPE cells produce levodopa, the precursor of dopamine. Dopamine is a neurotransmitter produced by nerve cells in the brain that progressively declines as the disease progresses. The RPE cells, which are normally found in the back of the eye, are cultured under standardized conditions and attached to the microscopic beads prior to implantation. The microcarriers are necessary for the cells to survive in the brain. The implanted cells serve as a new potential source of levodopa to enhance dopamine production where it is most needed.

An earlier pilot clinical study at Emory University implanted six advanced Parkinson's patients with cells on one side of the brain. These six patients experienced sustained improvements in motor function, averaging 41 percent at 24 months following treatment. In addition, there have been no safety concerns more than two years post treatment, according to neurosurgeon Dr. Roy A.E. Bakay, now at Rush and member of the Chicago Institute of Neurosurgery and Neuroresearch (CINN) medical group, who performed the surgical implantation for the study.

Along with Bakay, Rush neurologist Dr. Leonard Verhagen is the principal investigator for the Chicago site for this new Phase IIb, blinded STEPS study. Recruitment for the 68 patients for the study has recently begun. Each patient will be followed for approximately two years.

While the pilot study evaluated treatment on just one side of the brain, the STEPS research study will implant cells bilaterally, as Parkinson's affects both sides of the brain. Half of
'"/>

Contact: Mary Ann Schultz
Mary_Ann_Schultz@rush.edu
312-942-7816
Rush University Medical Center
16-Sep-2003


Page: 1 2 3

Related medicine news :

1. British hospitals need clinical ethicists
2. Lack of clinical trial participation may contribute to lower survival rates
3. Obtaining patient consent for clinical audit is unworkable without extra resources
4. Sharing clinical trial results with participants may be beneficial
5. Two years after gene therapy treatments, severe angina patients showed prolonged clinical benefit
6. PENN begins clinical trial of newest technology to treat thoracic aortic aneurysms
7. Most episodes of HIV blips not clinically significant in patients receiving HAART
8. NIAID seeks applicants to lead clinical trials units for revamped HIV/AIDS networks
9. New non-hormonal hot flash treatment set for clinical trial
10. Study naming hospitals in top 5% for clinical quality released by HealthGrades
11. Future of clinical medicine research is at risk, warns professor

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/16/2018)... ... November 16, 2018 , ... ... a historic agreement with Taikang Healthcare in China to provide clinical and management ... Hospital in Nanjing, the capital of Jiangsu Province in east central China. , ...
(Date:11/16/2018)... ... 16, 2018 , ... OnlineMasters.com, a trusted source for unbiased ... online physician assistant programs in the United States. The top-ranked programs were selected ... analyzed graduate schools across the country with only the top 10 making it ...
(Date:11/16/2018)... ... November 16, 2018 , ... Opioid drugs are commonly prescribed for back pain and ... cord and disrupt pain signals. The problem with these drugs, however, is that they are ... revealed that in 2016 and 2017, more than 130 people per day died as a ...
(Date:11/15/2018)... ... November 15, 2018 , ... November 13, ... platelet-rich plasma (PRP) therapies to her leading selection of minimally-invasive aesthetic treatments. PRP ... all-natural revitalization for any area of the body. Atagi Plastic Surgery & Skin ...
(Date:11/15/2018)... AUSTIN, Texas (PRWEB) , ... November 15, 2018 ... ... Surgery (ABFRPS) and the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) ... respectively. ABFRPS certifies plastic surgeons in the specialty field of facial plastics and ...
Breaking Medicine News(10 mins):
(Date:11/16/2018)... ... November 16, 2018 , ... MedVet is pleased ... Specialists (UVS), now known as MedVet Pittsburgh. The City Vets and VetNow divisions ... providing local veterinarians continued support and access to specialty and emergency veterinary care ...
(Date:11/16/2018)... Ala. (PRWEB) , ... November ... ... , the healthcare industry’s leading consumer experience solution provider, congratulates leading provider ... out from a competitive field of 1,000 entries across 17 categories for ...
(Date:11/16/2018)... ... November 16, 2018 , ... Through its Microbiome Grant ... study design, planning, sample collection, and analysis to team of researchers at University ... depressive symptoms, infant cognitive/behavioral development, and the gut microbiome. , The goal ...
Breaking Medicine Technology:
Cached News: